IceCure Medical (ICCM) Enterprise Value (2020 - 2025)
IceCure Medical (ICCM) has disclosed Enterprise Value for 5 consecutive years, with -$7.6 million as the latest value for Q4 2024.
- On a quarterly basis, Enterprise Value rose 31.62% to -$7.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$7.6 million, a 31.62% increase, with the full-year FY2024 number at -$7.6 million, up 31.62% from a year prior.
- Enterprise Value was -$7.6 million for Q4 2024 at IceCure Medical, up from -$11.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$7.6 million in Q4 2024 to a low of -$25.6 million in Q4 2021.
- A 5-year average of -$15.3 million and a median of -$11.1 million in 2023 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: crashed 213.56% in 2021, then soared 53.82% in 2023.
- IceCure Medical's Enterprise Value stood at -$8.2 million in 2020, then plummeted by 213.56% to -$25.6 million in 2021, then grew by 6.5% to -$24.0 million in 2022, then skyrocketed by 53.82% to -$11.1 million in 2023, then soared by 31.62% to -$7.6 million in 2024.
- Per Business Quant, the three most recent readings for ICCM's Enterprise Value are -$7.6 million (Q4 2024), -$11.1 million (Q4 2023), and -$24.0 million (Q4 2022).